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From Nucleotides to Nuanced Law: The 
Value of an Incremental Approach to 
Experimentation in State-Level Genetic 
Anti-Discrimination Legislation 
Katelyn Fisher 
16 U. MASS. L. REV. 311 
ABSTRACT 
A person’s genetic information tells a detailed story of what someone looks like, 
who her relatives are, and even what illnesses she may develop. This information, as 
enlightening as it may be, can be especially damaging when utilized in a 
discriminatory way. This Note explores how the protections under the Genetic Non-
Discrimination Act of 2008 will no longer be sufficient for protecting individuals 
from genetic discrimination as the use of genetic information becomes more 
commonplace. The questions become: Where do we start? How and where should 
protections that extend to circumstances not covered by GINA be created in a way 
that results in comprehensive protections against genetic discrimination? This Note 
proposes that an effective way to achieve comprehensive protection is through 
incremental change in genetic anti-discrimination law at the state level before 
legislative change is attempted at the federal level. It argues that experimentation in 
the laws at the state level will allow for thorough and meaningful protections by 
allowing the concerns regarding genetic discrimination in the individual states to 
catalyze their legislative responses and will allow the states to learn from other states 
in determining effective paths for its own genetic non-discrimination legislation. 
Finally, this Note will explore potential legal frameworks that states could use as a 
model for genetic anti-discrimination legislation. 
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I. INTRODUCTION 
At the brink of the new millennium, the movie Gattaca hit 
theaters.1 The film recounts the story of a young man shunned from 
society and disqualified from lucrative employment because he was 
not scientifically crafted to be the genetic highlight reel of his parents.2 
Gattaca seemed like a science fiction exaggeration, a mere reflection 
of what the world could become given the modern scientific 
advancements in genetics.3 In actuality, Gattaca emulated what was 
beginning to occur in the real world.4 Technological advancements, 
like predictive medicine, have since propelled genetics to the scientific 
forefront, making human genetic data readily available.5 
A person’s genetic data has the potential to significantly advance 
their medical treatment and biological self-understanding. However, 
use of that data may extend beyond the intended medical setting and 
into contexts where it may be used to her detriment.6 When genetic 
data reveals that a person is predisposed to disease, that fact could be 
honed into a tool of discrimination in the issuance of health insurance 
policies, employment, mortgage lending, and education, as just a few 
possibilities.7 With concerns regarding the use of medically acquired 
genetic data in nonmedical contexts becoming more prevalent, 
 
1 GATTACA (Columbia Pictures Industries 1997). 
2 Id. 
3 Id. 
4 See Michael R. Dohn, Personal Genomics and Genetic Discrimination: Is 
Increased Access a Good Thing?, 45 W. ST. L. REV. 107, 109–10 (2018) 
(explaining the history behind the discriminatory use of genetic information). 
“[The Eugenics] movement advocated for the sterilization of ‘undesirable’ 
individuals with the goal of improving the genetic composition of the population 
as a whole.” Id. This occurred in the early twentieth century in over 30 states, 
and “undesirable individuals” included those with physical or mental 
disabilities. Id. at 110. These laws have since been repealed, but in the 1970’s 
there was a rise in states requiring genetic tests for sickle cell anemia in African 
Americans and following that were discriminatory practices against those who 
possessed the gene. Id. at 110–11. 
5 Id. at 112. 
6 See id. at 112–13; see also Chadam v. Palo Alto Unified Sch. Dist., 666 Fed. 
App’x 615, 615 (9th Cir. 2016) (detailing how a student was removed from 
school due to the school’s belief that he had cystic fibrosis, when in actuality he 
merely had the genetic marker for the disease). 
7 See, e.g., Dohn, supra note 4, at 113 (describing the lack of limitations on the 
use of genetic information in determinations related to health insurance policies 
as a potential drawback). 
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Congress enacted the Genetic Information Nondiscrimination Act 
(“GINA”) in 2008.8 This Act created narrow protections for the use of 
genetic data in employment practices and health insurance 
determinations.9 GINA prevents both employers and health insurance 
companies from purchasing, requesting, or requiring an individual’s 
genetic information and from generally utilizing the information in a 
discriminatory fashion.10 
Though GINA provides limited protections against genetic 
discrimination, it fails to protect against instances of genetic 
discrimination in other industries.11 The potential use of genetic 
information in forums outside of the employment and insurance arenas 
is, as Gattaca demonstrated, astounding. Considering this, what is the 
legal remedy for a child who is denied equal access to education based 
on a genetic predisposition to a disease that has not physically 
manifested?12 What protections are afforded to a person who is denied 
a mortgage due to a genetic marker for a disease which may result in 
premature death, but for which they are only mildly symptomatic?13 
 
8 Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 2000ff (2018). 
9 See generally id. (setting forth the protections against genetic discrimination in 
health insurance and employment). 
10 Id. at § 101(d)(1)–(2). 
11 See Anya E. R. Prince & Benjamin E. Berkman, When Does an Illness Begin: 
Genetic Discrimination and Disease Manifestation, 40 J. L. MED. & ETHICS 655, 
657–58 (2012) (arguing that GINA is both limited in scope and also fails to 
define at what point a disease is considered physically manifested and therefore 
no longer protected under GINA); see also Dohn, supra note 4, at 113 
(highlighting the limited areas of GINA’s protection). 
12 E.g., Chadam v. Palo Alto Unified Sch. Dist., 666 Fed. App’x 615, 615 (9th Cir. 
2016). Though there was a remedy for this child under the ADA, the situation is 
possibly predictive of other similar situations where protection under the ADA 
may not be available. See Prince & Berkman, supra note 11, at 657 (under either 
GINA or the ADA, “[t]here is arguably no protection for individuals who have 
manifested some symptoms, but whose symptoms have not risen to the level of 
substantial limitations”). 
13 See Prince & Berkman, supra note 11, at 657–58. “GINA was structured such 
that it only provides protection against misuse of genetic information up until 
the point when an individual’s disease has manifested. It protects an individual 
with a genetic predisposition for a disease, but not an individual actively 
suffering from that disease.” Id. at 655. The point where a disease is considered 
to have manifested for GINA protection purposes is not defined in GINA. Id. 
This creates a gray area of situations where people may not be protected under 
GINA, as “there will be a gap between when an asymptomatic individual will be 
protected by GINA and when their symptoms will rise to the definition of 
disability protected under the Americans with Disabilities Act (ADA).” Id. at 
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GINA leaves such questions unanswered, and looking to the future, the 
actions in response to these questions could become devastating 
instances of discrimination based on genetics that do not currently 
have an adequate legal remedy.14 
As science evolves, laws governing genetic data must evolve 
alongside it. Experimentation—in both science and legal policy—
values adaptation and learning from applied experience to build on 
existing knowledge from past outcomes.15 This inherent need for 
flexibility in the law lends itself well to legislation at the state level.16 
As the availability and knowledge of genetic data evolves from its 
relative legal infancy, the nature and extent to which genetic 
discrimination will ultimately manifest is unknown.17 Legal reform at 
the federal level requires some consensus among the states. Due to the 
amount of time that will surely transpire before genetic discrimination 
is recognized in areas beyond health insurance and employment, trying 
to combat it at the federal level would be overly complex and 
cumbersome.18 In 2008, the breadth of areas in which genetic 
discrimination could arise was not concretely established, and if 
specific contexts were considered they were not regarded as 
 
657. A person is protected from discrimination based on a disability under the 
ADA if they have “symptoms [that] substantially limit a major life activity.” Id. 
14 See Dohn, supra note 4, at 126 (“[GINA] ‘does nothing to prohibit 
discrimination in life insurance, disability insurance, long term care insurance, 
or commercial transactions.’ The Act also does not address genetic 
discrimination in the public education system or in housing.”). 
15 Cf. James W. Fosset et al., Federalism & Bioethics: States and Moral Pluralism, 
37 HASTINGS CTR. REP. 24, 25 (2007) (discussing the benefits of a federalist 
approach to bioethics reform as “offer[ing] considerable advantages in 
managing the political conflicts that inevitably arise from moral pluralism, 
particularly around questions where there is no clear national consensus.”). 
16 Id. States can manifest the ability to adapt to political and moral conflict and can 
be strengthened through incremental legislative experimentation. See infra note 
128. 
17 See Jessica L. Roberts, Preempting Discrimination: Lessons from the Genetic 
Information Nondiscrimination Act, 63 VAND. L. REV. 439, 481 (2010) (arguing 
that basing legislation on fear of future harms is problematic, as “Congress is 
incapable of anticipating how the discrimination will actually operate if it indeed 
occurs”). 
18 Cf. Fosset et al., supra note 15, at 28 (in the context of bioethics generally, states 
can deal with interstate policy variations and “are able to take action on complex 
and controversial bioethical issues if the federal government is unable to do 
so”). 
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sufficiently problematic to warrant protection.19 The states will vary in 
their recognition of genetic discrimination as a pervasive issue in areas 
GINA does not cover; and this disjunction of time and scope of 
coverage makes a federal consensus unlikely.20 
A state-by-state experimental approach offers a method of legal 
advancement which reconciles the need for more comprehensive 
genetic antidiscrimination legislation with the unpredictable nature of 
the field to be regulated.21 States could enact laws tailored to local 
discrimination issues that not only go beyond GINA’s limited 
protections, but could also serve as a legislative blueprint for other 
states to adopt as applicable.22 This represents an incremental 
approach; relying on smaller, specific instances of experimentation at 
the state level to respond to the prospective issues that genetic 
discrimination presents, thereby advancing the progress of 
comprehensive genetic antidiscrimination legislation.23 
This Note will begin with the history of genetic research and how 
science has led to the modern uses of genetic material. It will then 
address the federal response to the increasing use and prevalence of 
genetic information by passing GINA, and how the momentum of 
scientific advancements has rendered GINA’s protections inadequate. 
This Note proposes that protections beyond GINA must come in the 
form of state-level legislation and focuses on the need for changes in 
the state laws to be made in a deliberate, incremental fashion so states 
have the freedom to experiment before the enactment of a 
comprehensive federal law. The discussion then turns to the benefits of 
using this approach to facilitate the legislative changes and will 
 
19 Genetic Information Nondiscrimination Act of 2008 § 2(4)–(5), 42 U.S.C. 
§ 2000ff (2018). 
20 Cf. Fosset et al., supra note 15, at 25 (“state legislatures and courts have been 
and continue to be major participants in the establishment and implementation 
of bioethics policy”). 
21 Id. 
22 Cf. Robert A. Mikos, The Evolving Federal Response to State Marijuana 
Reforms, 26 WIDENER L. REV. 1, 18 (2020) (when creating legislation, in the 
context of federal marijuana regulation, it is “easier for a legislature to build 
consensus behind a narrow, targeted measure” rather than “more comprehensive 
reforms”). 
23 See Charles E. Lindblom, The Science of “Muddling Through,” 19 PUB. ADMIN. 
REV. 79, 85 (1959) (effective policy change can be made through a series of 
minor changes that consecutively build upon the successes of previous policy). 
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conclude with models the individual states could follow as they 
develop genetic nondiscrimination legislation. 
II. THE RISE OF THE UNDERSTANDING AND USE OF GENETIC 
INFORMATION 
While the complex mapping of the human genome was a 
monumental accomplishment in science, it was also a slow and 
painstaking process.24 Like most scientific discoveries, as the 
understanding of the human genome deepened, so did its application.25 
It is true that some of the uses of genetic information are relatively 
benevolent, aimed at improving medical treatment with 
recommendations based on the person’s unique genetics.26 The fear is 
that this newfound accessibility of genetic data also invites invasions 
of privacy and discrimination.27 Consequently, the federal government 
enacted GINA, which prohibits discrimination based on genetics in 
employment and health insurance settings.28 The continued scientific 
advancements in this field will inherently result in genetic information 
being more readily accessible than ever before, making GINA’s 
limited protections ineffective.29 
A. Brief History of Genetic Information 
Through a scientific lens, a human’s “genetic information” is 
relatively straightforward: it refers to the entirety of the human 
genome. The genome is a sequence of millions of chemical building 
blocks (DNA), constructed in a way that is unique to each individual, 
 





27 Genetic Information Nondiscrimination Act of 2008 § 2, 42 U.S.C. § 2000ff 
(2018); see also Roberts, supra note 17, at 480–81 (discussing that the creation 
of GINA was predicated on a fear of genetic discrimination in the workplace 
and by health insurance companies). 
28 See generally Genetic Information Nondiscrimination Act. 
29 See Genetic Discrimination, NAT’L HUM. GENOME RES. INST., 
https://www.genome.gov/about-genomics/policy-issues/Genetic-Discrimination 
[https://perma.cc/J7WS-VGEF] [hereinafter Genetic Discrimination]. 
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and controls all the physical characteristics of a particular person.30 
The United States government started the Human Genome Project in 
1990 for the purpose of identifying all human genes.31 Spanning nearly 
fifteen years, the Project was completed in 2003 and disclosed the 
sequence of nearly the entire human genome.32 Genetic information is 
the foundation for every function in the human body, it determines 
both basic attributes (hair or eye color) and the most complex of bodily 
processes (protein creation).33 Apart from being indicative of a 
person’s basic traits, genetic information can also be considered to 
tailor medical treatment methods and predict health conditions.34 In a 
sense, genes are a window into a person’s medical future because they 
reveal predispositions to potential illnesses.35 
As with any prediction, genes do not relay certainty, a person may 
possess a gene signaling an increased risk for an illness or disease that 
might never actually manifest.36 Thus, the use of a person’s genetic 
data could lead to discrimination based on an illness she never actually 
 
30 See generally A Brief Guide to Genomics, NAT’L HUM. GENOME RES. INST., 
https://www.genome.gov/about-genomics/fact-sheets/A-Brief-Guide-to-
Genomics [https://perma.cc/HSL8-7NQ4]. 
31 See AMANDA K. SARATA & JODY FEDER, CONG. RESEARCH SERV., RL34584, 
THE GENETIC INFORMATION NONDISCRIMINATION ACT OF 2008 (GINA) 1 n.1 
(2015). 
32 Timeline of the Genetic Information Nondiscrimination Act (GINA), NAT’L 
HUM. GENOME RES. INST., https://www.genome.gov/about-genomics/policy-
issues/timeline-genetic-information-nondiscrimination-act-GINA 
[https://perma.cc/3W7V-39TV]. 
33 Phenotype, NAT’L HUM. GENOME RES. INST., https://www.genome.gov/genetics-
glossary/Phenotype [https://perma.cc/2Z98-MML4] (explaining the different 
characteristics controlled by genes); see also Dohn, supra note 4, at 112–13 
(discussing how DNA collected in at-home testing kits can be used to discover 
various characteristics about an individual). 
34 See Bradley A. Areheart & Jessica L. Roberts, GINA, Big Data, and the Future 
of Employee Privacy, 128 YALE L.J. 710, 719 (2019) (describing the most 
important use of genetic information in science as being disease prediction); 
Genetics vs. Genomics Facts Sheet, NAT’L HUM. GENOME RES. INST., 
https://www.genome.gov/about-genomics/fact-sheets/Genetics-vs-Genomics 
[https://perma.cc/J8UM-CMZS] (explaining the use of genetic information in a 
healthcare setting with an emphasis on understanding how genes interact with 
the environment to cause disease). 
35 Areheart & Roberts, supra note 34, at 719. 
36 A Brief Guide to Genomics, supra note 30 (explaining that genetics play a role 
in the manifestation of disease, but their manifestation may be subject to the 
influence of environmental factors). 
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experiences; and would have remained uncovered but for the scrutiny 
of her genes. 
B. Genetic Discrimination 
 The legal classification of genetic information is far more 
complex than its scientific counterpart. From a legal standpoint, 
genetic information encompasses an individual’s genetic tests, which 
include any test that analyzes a person’s DNA to provide information 
regarding the individual’s genetic sequence, genetic mutations, and 
changes in their genome.37 It also includes the genetic data and 
“manifestation of a disease or disorder” in that individual’s family 
members.38 
The broad scope of the legal definition of genetic information is 
indicative of the problems presented by its unregulated use and 
highlights the fields which require legal protection.39 The conclusions 
that can be drawn about an individual from the genetic and health data 
of their relatives creates an array of privacy concerns.40 Genetic 
privacy concerns are heightened by the sensitive information it can 
reveal about an individual. Genes can express not only predispositions 
for illness and disease, but other traits that a person may desire to keep 
private, such as stigmatized personality traits like addictive tendencies 
and aggression.41 Considering that the genetic information from one 
person could be indicative of their entire family’s genetic information, 
it has the potential to trigger the discrimination of an entire group of 
people.42 
 
37 Genetic Information Nondiscrimination Act of 2008, § 201(4), (7), 42 U.S.C. 
§ 2000ff (2018). 
38 Id. at § 201(4)(A)(iii). 
39 See Dohn, supra note 4, at 126–27 (identifying several categories that are 
outside the scope of GINA where protection against genetic information 
discrimination should be required). 
40 Id. 
41 See Jessica L. Roberts, The Genetic Information Nondiscrimination Act as an 
Antidiscrimination Law, 86 NOTRE DAME L. REV. 597, 616–17 (2011) 
(highlighting the collection of genetic information as a privacy concern based on 
the availability of sensitive information); see also Andreas Meyer-Lindenberg et 
al., Neural Mechanisms of Genetic Risk for Impulsivity and Violence in Humans, 
103 PROC. OF THE NAT ACAD. OF SCI. 6269, 6272 (2006) (explaining the 
complexities of correlating the prevalence of certain genes with increased levels 
of aggression given the presence of other factors including environmental and 
social). 
42 Roberts, supra note 41, at 617. 
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For those individuals with genetic predispositions that do manifest 
and can be diagnosed, protections against discrimination may exist 
under the Americans with Disabilities Act (“ADA”).43 The ADA 
provides protections for people based on both physical and mental 
disabilities.44 However, protections for genetic predispositions to 
disease that do not manifest are not within the scope of the ADA.45 
Protections for people with unmanifested-but-potential medical 
issues identified through genetic sequencing were comparatively 
absent before the enactment of GINA, as the pervasive potential of 
genetic information usage was only beginning to arise.46 This 
expansion of genetic information in the medical field highlighted a 
new form of possible discrimination predicated on the mere possibility 
of illness occurring.47 For instance, historically, health insurance 
companies were not barred from considering a person’s genetic 
predisposition for health conditions when deciding whether to issue a 
policy.48 Health insurance providers were apt to raise prices to cover 
illnesses a person was predisposed to or even deny issuing a policy 
based on genetic markers and predispositions.49 It was the 
vulnerability of individuals in cases like this that prompted the 
enactment of GINA.50 
C. The Enactment of GINA 
In 2008 Congress noted a “current explosion in the science of 
genetics,” which motivated them to enact GINA as a proactive 
measure to combat genetic discrimination.51 The concerns over 
 
43 See Prince & Berkman, supra note 11, at 657 (protection is dependent on 
satisfying the definition of disability under the Act). 
44 See id. (ADA is limited to protecting symptoms that substantially limit major 
life activity). 
45 Id. 
46 See id. at 655 (GINA was enacted in response to technological advancements in 
genetic science). 
47 See id. at 655–56. 
48 See Areheart & Roberts, supra note 34, at 722 (discussing the lack of protection 
for genetic discrimination by health insurers before both GINA and the 
Affordable Care Act). 
49 Id. 
50 Id. at 723–24. 
51 Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 2 (2018); 
Roberts, supra note 41, at 625 (“GINA is a forward-looking statute—designed 
to preempt a variety of discrimination before it becomes entrenched”). 
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potential discriminatory uses of genetic information came on the tails 
of the Human Genome Project being started.52 GINA was originally 
introduced in Congress by Representative Louise Slaughter in 1995 
and included protections against genetic discrimination in health 
insurance, but the bill died before it could be voted on by Congress.53 
The bill was reintroduced in 1999 with the additional protection 
against genetic discrimination in employment but it failed to pass both 
houses of Congress once again.54 The 1999 bill was reintroduced in 
2002 by Senator Olympia Snowe.55 After two more unsuccessful 
introductions, GINA was signed into law in 2008.56 
The scope of GINA is highly limited, concerning only the “misuse 
of genetic information in health insurance and employment.”57 In the 
context of health insurance, GINA prohibits health insurance 
companies from “request[ing], requir[ing], or purchas[ing] genetic 
information for underwriting purposes.”58 In the area of employment, 
employers cannot “request, require, or purchase genetic information 
with respect to an employee or a family member of the employee.”59 
Additionally, GINA generally proscribes an employer from 
discriminating against an employee on the basis of their genetic 
information.60 
Outside of prohibiting employers and health insurers from 
purposefully gathering genetic information and using that information 
to explicitly discriminate against people, GINA leaves much to be 
desired.61 Even the limited protections that are granted are subject to 
exceptions and thus not entirely comprehensive.62 For example, GINA 
does not provide recourse when health insurance companies 
 
52 See SARATA & FEDER, supra note 31, at 3–4. 





57 Genetic Information Nondiscrimination Act of 2008, § 2(1), 42 U.S.C. § 2000ff 
(2018). 
58 Id. § 101(d)(1). 
59 Id. § 202(b). 
60 Id. § 202(a). 
61 Roberts, supra note 41, at 640. 
62 See, e.g., Roberts, supra note 17, at 456–57. 
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incidentally acquire a person’s genetic information.63 Apart from this 
limited coverage, genetic-based discrimination remains unchecked and 
unpunishable in other circumstances. 
III. FEDERAL AND STATE ATTEMPTS TO ADDRESS THE SHORTFALLS 
LEFT BY GINA 
As expressed in the congressional findings of GINA, the science of 
genetics is continually evolving which, in turn, expands the potential 
use for genetic information.64 As a result, even though GINA was 
meant to afford individuals protections against genetic discrimination 
in the employment and health insurance fields it does nothing to 
prevent genetic discrimination in other environments.65 For example, a 
school in California was accused of removing a young male student 
because he had a genetic marker that predisposed him to cystic 
fibrosis.66 In that case, the school perceived the student as having a 
disability because of his predisposition and removed him based on that 
perception, which the court held was prohibited under the ADA.67 This 
example of genetic discrimination in education showcases just one of 
the venues not covered by GINA. But what would happen if the 
genetic predisposition were for a characteristic that could not be 
perceived as a disability under the ADA, like aggression?68 What 
remedy is available for the person who is denied being considered as a 
foster parent because they are predisposed to aggression? Given the 
continuous advancements in technology and science, this is likely to 
be just one of a myriad of instances of genetic discrimination not 
currently prohibited by law.69 
GINA is not a comprehensive statutory scheme and contains 
several notable exceptions in the fields it does cover. In employment, 
 
63 Id. at 456. 
64 Genetic Information Nondiscrimination Act § 2. 
65 See id. 
66 Chadam v. Palo Alto Unified Sch. Dist., 666 Fed. App’x. 615, 616 (9th Cir. 
2016). 
67 Id. 
68 See generally Meyer-Lindenberg et al., supra note 41, at 6272 (illustrating the 
correlation between an individual’s genes and a predisposition for violent 
behavior and aggression). Because the predisposition for aggression is not a 
manifestation of a disability, it is unlikely to be covered by the ADA. See Prince 
& Berkman, supra note 11, at 657. 
69 See Dohn, supra note 4, at 128–29. 
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GINA fails to prohibit the military from utilizing genetic information 
of applicants in the hiring process.70 Nor does the Act extend to 
employers with fewer than fifteen employees.71 As for health 
insurance, GINA does not cover affiliate realms such as life insurance, 
long-term care insurance, or disability insurance.72 As it stands, many 
employers and the health insurance equivalents are not prohibited from 
considering an individual’s genetic information. 
Other federal laws minimally supplement the provisions of 
GINA.73 The Health Insurance Portability and Accountability Act 
(“HIPAA”) is a law that governs health-related information privacy.74 
With the passage of GINA, HIPAA now includes genetic information 
within the umbrella of health information, so it cannot be considered 
by health insurance providers when determining plans and 
premiums.75 GINA could also possibly be supplemented by the ADA, 
which prohibits discrimination in several settings, including 
employment and public accommodations.76 In 1995, the Equal 
Employment Opportunity Commission (“EEOC”) interpreted the ADA 
to cover “genetic information relat[ed] to illness, disease, or other 
disorders.”77 Additionally, the EEOC considered that the ADA could 
be applicable to preventing genetic discrimination in employment 
settings.78 Finally, GINA is supplemented by the Affordable Care Act 
of 2010 (“ACA”).79 The Act requires health insurance companies to 
provide health insurance coverage to any person who requests it.80 
Additionally, the ACA indirectly prohibits considering genetics when 
determining the cost of coverage by excluding genetics from the 
 





75 Id. Unfortunately, HIPAA only protects the privacy of genetic information in 
health insurance settings. Id. 
76 Id. 
77 Id. 
78 Id. It is important to note that the interpretation by the EEOC does not legally 
mandate a court to interpret the ADA as including genetic discrimination, and its 
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narrow list of factors companies may use to vary the price of a 
policy.81 
Most states have adopted similar restrictions to those included in 
GINA.82 However, some states go further and provide protections 
against genetic discrimination in venues beyond GINA’s coverage.83 
While this “small handful of states” have legislation governing the 
disclosure of genetic information, they lack antidiscrimination 
legislation specifically for genetic information.84 Yet the existence of 
such legislation by the states clearly demonstrates their increasing 
appreciation of the unique dangers attendant to the misuse of genetic 
information. 
As the legal concept of genetic discrimination remains nascent, the 
states affording more protection against genetic discrimination than 
GINA offer insight into the areas that some states recognize as 
requiring additional protection. For example, California has enacted 
the California Genetic Information Nondiscrimination Act 
(“CalGINA”),85 which integrated the prohibition against genetic 
discrimination into its civil rights law, making it unlawful to 
discriminate against a person based on their genetics in all state-funded 
business practices.86 This includes industries such as housing, 
mortgage lending, and education.87 This approach to adopting laws 
varying in degrees of protection, comparative to GINA, may result in a 
patchwork of protections among the states, but it may also achieve a 
comprehensive framework long before the federal law catches up.88 
 
81 Id. (health insurers are permitted to change premiums based on limited factors 
such as age and area of residence). 
82 See generally Sally J.T. Necheles, Cause of Action for Violation of the Genetic 
Information Nondiscrimination Act, 71 CAUSES OF ACTION 2D 537 § 73 (Supp. 
2020) (illustrating the existing various state variations of GINA). 
83 Dohn, supra note 4, at 124. 
84 See id. (Alaska, Arizona, California, Florida, and Nevada, deal with genetic 
information in the context of privacy rather than discrimination). 
85 CalGINA, ch. 261, 2011 Cal. Stat. 2774 (codified in scattered sections of the 
California Codes). 
86 Id. 
87 See Areheart & Roberts, supra note 34, at 725 n.58 (discussing the protections 
against genetic discrimination afforded under CalGINA). 
88 Cf. Summer Johnson, Editorial, Federalism, Federalism Everywhere, AM. J. 
BIOETHICS, Nov. 2008, at 1–2 (in the context of state law governing human 
research subjects, “[p]erhaps national consensus will emerge from the states”). It 
follows that one possible outcome of state level experimentation in the law 
governing genetic discrimination could result in a common understanding of the 
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IV. INCREMENTALISM AS A PROPOSED SOLUTION 
Considering the shortfalls within GINA and the ever-expanding 
use of genetic information, legislative change is warranted. There are 
two major benefits to starting this change at the state level. First, state-
level legislation is less daunting and can be enacted faster than federal 
law. Second, incremental legislation allows for experimentation that 
can result in a framework of laws which represent the specific needs of 
the individual states to combat genetic discrimination.89 
A. State-Level Experimentation to Effectuate the Creation of 
Genetic Antidiscrimination Laws 
An incremental approach to genetic antidiscrimination legislation 
would both accurately reflect the needs of the several states in 
providing protection to their citizens and catalyze change in the law 
sooner than federally-enacted legislation.90 More specifically, this 
state-level experimentation would foster both progressive awareness 
and recognition of genetic discrimination as a growing cause for 
concern.91 The focus on creating genetic anti-discrimination legislation 
at the state level could avoid two issues that may arise if the law were 
initially enacted at the federal level. First, making changes at the state 
level could ameliorate the slow pace of federal legislation related to 
genetic discrimination. Second, this approach could help close the 
inevitable gaps that result from enacting federal legislation in a 
developing area of law.92 
Federal anti-discrimination statutes provide a uniform framework 
that specifies precisely which areas of society lawmakers considered 
merited protection. This uniformity would be particularly ineffective 
for our purposes because the varying degrees to which states encounter 
genetic discrimination would make it difficult to reach a consensus on 
 
issue among the states. See Fosset et al., supra note 15, at 25 (highlighting how 
these differences allow for experimentation resulting in better law). 
89 Lindblom, supra note 23, at 85 (“small variations from present policy makes the 
most of available knowledge”). 
90 See Fosset et al., supra note 15, at 25. 
91 See Lindblom, supra note 23, at 85. 
92 JOHN V. SULLIVAN, HOW OUR LAWS ARE MADE, H.R. Doc. No. 110–49, at 1 
(2007). 
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what areas to protect.93 If the federal government decided to update 
and expand current genetic antidiscrimination legislation, the process 
would be laborious. In the time it would take for the bill to be 
proposed, debated, and enacted, new areas of discrimination would 
likely surface and be excluded from protection.94 This leaves the 
federal legislature in a challenging position: attempt to pass a general 
legislative ban on genetic discrimination or predict other industries 
where protections against genetic discrimination may be warranted. 
Both options could result in insufficient protections because the law, at 
some point, must yield to the unpredictability of scientific 
advancement.95 
Implementing genetic antidiscrimination laws at the state level 
would advance the understanding of circumstances that may require 
protection, and provide each state the opportunity to craft specific laws 
based upon what protections are necessitated.96 Individual states are 
more familiar with the unique needs desires, and limitations of their 
constituents because of their proximity to them.97 This connection 
allows for genetic antidiscrimination laws governing different 
instances of discrimination to be enacted more efficiently in the 
 
93 Cf. Fosset et al., supra note 15, at 28 (discussing how states are better equipped 
to handle a lack of national consensus in the field of bioethics due to a more 
intimate understanding of local values and practicalities). 
94 Cf. id. at 32 (in the context of stem cell research a “decentralized pattern of 
policy development also provides a desirable means to develop national 
answers”). In an area of law where there is unlikely to be national answers, the 
will of the people regarding genetic discrimination legislation would be better 
reflected if the law was changed at a level most intimate with the needs of the 
citizens. Id. at 28. 
95 Cf. id. at 27–28 (political “cross-pressures” on the national level can make 
federal action impossible and therefore put states in a better position to pass 
comprehensive legislation on important issues). 
96 Cf. id. at 30 (“Allowing for variations in program structure and implementation 
both permits the tailoring of program management to local conditions and 
allows other states and the federal government to gain valuable information on 
the most effective means of improving program performance.”); Kathryn L. 
Tucker, Federalism in the Context of Assisted Dying: Time for the Laboratory to 
Extend Beyond Oregon, to the Neighboring State of California, 41 WILLAMETTE 
L. REV. 863, 879–80 (2005) (Oregon serving as a laboratory for the possibility 
of physician-assisted dying). 
97 Fosset et al., supra note 15, at 28. 
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individual states.98 A state has the opportunity to act swiftly to propose 
legislation prohibiting discrimination from continuing within the state, 
which promotes a government that is “more immediately accountable 
to individual[]” citizens of that state.99 If protections were enacted at 
the federal level the long waiting periods would allow the 
discrimination to perpetuate in unprotected areas, compounding the 
injury to those subjected to the discrimination. Furthermore, fears over 
the unregulated use of the genetic information could chill the 
progression of genetic advancements.100 
Enacting legislation at the state level could offer greater 
protections to the citizens of individual states without violating their 
rights under federal law. The Supremacy Clause of the United States 
Constitution prevents states from reducing protections provided by 
federal law.101 However, state laws that add protections to the floor 
established by GINA would not conflict with federal law.102 With this 
in mind, citizens would enjoy increased protections under both the 
federal and state laws.103 This model will result in framework of 
protective legislation that is more comprehensive in a wider breadth of 
settings than GINA.104 
 
98 See Johnson, supra note 88, at 1 (arguing that in bioethics, states may enact 
needed regulations if the federal government is failing to do so or is not doing it 
fast enough). 
99 Arthur C. D’Andrea, Note, Federalizing Bioethics, 83 TEX. L. REV. 1663, 1694 
(2005); see also Tucker, supra note 96, at 879–80; Fosset et al., supra note 15, 
at 30. 
100 See Roberts, supra note 41, at 603–06 (GINA was passed as a way to mitigate 
fears associated with unregulated use of genetic information and to encourage 
participation in genetic testing to improve research and benefits to individuals); 
see also Annet Wauters & Ine Van Hoyweghen, Global Trends on Fears and 
Concerns of Genetic Discrimination: A Systematic Literature Review, 61 J. 
HUM. GENETICS 275, 279–81 (2016) (discussing modern fears of genetic 
discrimination of specific genes). 
101 Preemption, CORNELL L. SCH.: LEGAL INFO. INST., https://www.law.cornell.edu
/wex/preemption [https://perma.cc/DC79-Z2EW]. This means any state law that 
affords less protection than GINA directly conflicts with federal law and is 
unenforceable. Id. 
102 Id. 
103 See, e.g., CalGINA, ch. 261, 2011 Cal. Stat. 2774 (codified in scattered sections 
of the California Codes). 
104 See id. CalGINA provides significant protections beyond the scope of GINA 
while retaining GINA protections. 
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There are likely endless ways in which genetic discrimination 
could manifest as science in the field continues to develop.105 States 
and their respective legislatures and citizens, may differ in their 
perspective of which rising issues should be a priority for legislative 
action.106 The law in this sense is analogous to the human genome: 
variation leads to evolution.107 The power of a state to enact genetic 
anti-discrimination legislation is within the state’s general “police 
power,” which allows the state to create regulations controlling the 
welfare of its citizens so long as the law does not conflict with 
established federal laws.108 
Consider the implications of the following example. State A is 
experiencing a significant issue with the usage of genetic information 
for prejudicial purposes by its banks, which are considering the genetic 
data of applicants when deciding whether to issue a loan or rejecting 
loans for those who have the genetic marker for a disease.109 Under 
this Note’s proposed model, State A may identify the discriminatory 
conduct, and propose and enact legislation that would prevent it from 
continuing in that setting. Subsequently, if State B is experiencing the 
same issue, it may either implement legislation using State A as a 
blueprint, or it could enact its own unique legislation. States where 
citizens are experiencing genetic discrimination more pervasively can 
serve as models for how such discrimination is handled so other states 
 
105 See Fosset et al., supra note 15, at 29 (“[A]n active role for states in developing 
and implementing bioethical policy provides for experimentation in the design 
and implementation of complex bioethical decisions.”). 
106 See id. at 28 (“Federalism tolerates great diversity in domestic policy . . . .”). 
107 Tucker, supra note 96, at 879 (Experimentation in bioethics law in the context 
of assisted dying “is exactly what Justice Brandeis contemplated in his famous 
passage: ‘[i]t is one of the happy incidents of the federal system that a single 
courageous state may, if its citizens choose, serve as a laboratory and try novel 
social and economic experiments without risk to the rest of the country.’” 
(quoting New State Ice Co. v. Liebermann, 285 U.S. 262, 311 (1932) (Brandeis, 
J., dissenting))). 
108 Police Power, BRITANNICA, https://www.britannica.com/topic/police-power 
[https://perma.cc/D875-8DYY]. 
109 See generally Kaitlyn Dowling, Genetic Discrimination in Housing and 
Lending: What’s the Risk?, PETRIE -FLOM CTR.: BILL OF HEALTH (Nov. 15, 
2019), https://blog.petrieflom.law.harvard.edu/2019/11/15/genetic-discrimin
ation-in-housing-and-lending-whats-the-risk/ [https://perma.cc/CQ56-YLJH] 
(providing information on the general concern regarding genetic discrimination 
in housing and mortgage lending). 
2021 Nucleotides to Nuanced Law 329 
could then emulate that approach.110 This allows the states to learn 
from one another by analyzing both the pitfalls and successes of the 
legislation of other states.111 With states serving as “laboratories of 
democracy,” the passage of time allows states to contribute to the 
collective understanding of genetic discrimination, resulting in 
expansive genetic anti-discrimination laws.112 
An incremental approach by states will hasten the acceptance of 
genetic discrimination as a pervasive issue at the federal level. Passing 
more effective legislation against genetic discrimination at the state 
level should be effectuated to give states the opportunity to respond to 
new forms of discrimination as they arise.113 While comprehensive 
federal legislation remains the ultimate goal, it can be achieved more 
easily once states have had time to appreciate the value of their 
legislation and experiment with implementation strategies.114 The 
present circumstances surrounding genetic antidiscrimination 
legislation are well-suited for an incremental approach because there is 
a lack of acceptance of its importance. This disparity in acceptance of 
genetic discrimination as a tangible issue is demonstrated by the 
majority of states not enacting any legislation to extend the limited 
protections offered by GINA.115 
 
110 Tucker, supra note 96 at 864 (if a state chooses to enact a novel law it “would 
do a service to the rest of the nation, as other states watch another state enact 
and implement such a law”). 
111 Id. at 880 (“It has been widely recognized that the states’ ability to experiment 
with local solutions to public health problems is especially critical to the 
development of wise public health policy.”). 
112 See id. at 879–80. 
113 James E. Krier & Mark Brownstein, On Integrated Pollution Control, 22 
ENVTL. L. 119, 126 (1992) (discussing how a comprehensive approach to 
solving environmental problems can lead to unrealistic reforms that ignore the 
“imperfections of the real world”). In the context of environmental policy, it is 
understood “that everything is interconnected, we fall into the logical fallacy of 
believing the only way to improve those interconnections is to deal with them all 
at once.” Id. at 125. 
114 Lindblom, supra note 23, at 81 (before legislators can enact laws based on 
public preferences, there must be public discussion to ensure a majority 
preference accurately reflects the will of the public). 
115 See generally Genome Statute and Legislation Database, NAT’L HUM. GENOME 
RES. INST., https://www.genome.gov/about-genomics/policy-issues/Genome-
Statute-Legislation-Database [https://perma.cc/99Y6-SKTU] (listing current and 
recently pending state level legislation that concerns genetic discrimination, of 
which there are few). 
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Just as the understanding of genetics took years to develop, a fully 
comprehensive framework of the genetic antidiscrimination law will 
not be immediately realized in “one fell regulatory swoop,” but rather 
it will be gradual as the circumstances in which genetic discrimination 
can occur come to fruition.116 The path to effective and robust 
“[p]olicy does not move in leaps and bounds.”117 States are likely to 
disagree on approaches to understanding and tackling problems that 
new issues present.118 Because the states vary in the amount of 
urgency they place on expanding GINA’s protections, it is important 
to prioritize progress over flawless legislation, as “perfect must not 
become the enemy of the good.”119 
The expansion of regulation of genetic antidiscrimination 
legislation at the state level will allow for legislatures to develop novel 
policy change on a trial-and-error basis within the state.120 That state 
can then assess the success of the approach and modify it as necessary 
which could incline other states to adopt a similar law. Implementing 
laws governing genetic discrimination this way will also allow states 
to work through the inevitable limitations of human knowledge when 
working with a scientific moving target.121 Gradual change to the law 
allows states to focus on instances of genetic discrimination that are 
recognized by both scientists and society, which maximizes the benefit 
 
116 J.B. Ruhl & James Salzman, Climate Change, Dead Zones, and Massive 
Problems in the Administrative State: A Guide for Whittling Away, 98 CALIF. L. 
REV. 59, 62 (2010) (quoting Massachusetts v. Envtl. Prot. Agency, 549 U.S. 
497, 524 (2007)). In the context of environmental regulation, instead of making 
drastic changes in regulation, environmental agencies “instead whittle away at 
them over time, refining their preferred approach as circumstances change and 
as they develop a more-nuanced understanding of how to best proceed.” Id. 
117 Lindblom, supra note 23, at 84. 
118 Id. at 85–86 (“[T]he incremental pattern of policy-making fits with the multiple 
pressure pattern. For when decisions are only incremental−closely related to 
known policies, it is easier for one group to anticipate the kind of moves another 
might make and easier too for it to make correction for injury already 
accomplished.”). 
119 Krier & Brownstein, supra note 113, at 128. 
120 Cf. Erwin Chemerinsky et al., Cooperative Federalism and Marijuana 
Regulation, 62 UCLA L. REV. 74, 78 (2015) (in the context of marijuana, 
“willing states [should be allowed] to experiment with novel regulatory 
approaches while leaving the federal prohibition intact for the remaining 
states”). 
121 See Lindblom, supra note 23, at 85 (“given the limits on knowledge within 
which policy-makers are confined, simplifying by limiting the focus to small 
variations from present policy makes the most of available knowledge”). 
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of present awareness without attempting to blindly predict future areas 
of concern.122 After sufficient experimentation, the successes of the 
state-level legislative efforts could be integrated into a series of model 
laws that other states and the federal government could use when 
engaging in genetic antidiscrimination reform.123 The incremental 
approach thus prevents legislatures from prematurely enacting 
legislation by first educating the legislators on new areas of the law 
requiring massive policy reform.124 Although incremental change is 
gradual, in the sense that it is comprised of minor and unassuming 
steps, it has the potential to be a faster route to comprehensive genetic 
discrimination protection than slow but major legislative alterations.125 
Given the uncertainty surrounding the sectors of society that will 
definitively require protection, this approach allows each state to 
create legislation based on their citizens’ unique needs by evaluating 
the state’s unique political and social opinions to pinpoint areas of 
vulnerability.126 The various states developing their own 
comprehensive genetic nondiscrimination law will result in a body of 
legislation and public policies beneficial to all states.127 These policies 
will also be instrumental in the furtherance of protective legislation for 
states in the future. By having an array of legislators and policymakers 
creating tailored solutions in areas of genetic discrimination law states 
could render more effective legislation. 
 
122 Id. 
123 See generally Deanna Barmakian, Uniform Laws and Model Acts, HARV. L. 
SCH. LIBR. (Nov. 4, 2020), https://guides.library.harvard.edu/law/unifmodelacts 
[https://perma.cc/F8FD-LBZ9] (illustrating the use of model laws as a basis of 
state legislation that can be adopted in whole or in part by a state). 
124 Lindblom, supra note 23, at 85 (“Non-incremental policy proposals are therefore 
typically not only politically irrelevant but also unpredictable in their 
consequences.”). 
125 See Charles E. Lindblom, Still Muddling, Not Yet Through, 39 PUB. ADMIN. 
REV. 517, 520 (1979) (in the context of political change, “[a] fast-moving 
sequence of small changes can more speedily accomplish a drastic alteration . . . 
than can an only infrequent major policy change”). 
126 See Ryan B. Stoa, Marijuana Agriculture Law: Regulation at the Root of an 
Industry, 69 FLA. L. REV. 297, 362–63 (2017) (discussing an incremental 
approach in the regulation of marijuana farming). 
127 See Michael S. Sparer et al., Inching Toward Incrementalism: Federalism, 
Devolution, and Health Policy in the United States and the United Kingdom, 36 
J. HEALTH POL., POL’Y & L. 33, 42 (2011) (“[F]ederalism also creates legislative 
and regulatory ‘opportunity points’ that lead to a more expansive set of public 
policies.”). 
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B. Legal Models States Could Follow to Address Genetic 
Antidiscrimination 
Governments in other countries have adopted various methods for 
creating legislation prohibiting genetic discrimination.128 Britain for 
example, has a moratorium in place on the use of genetic information 
in the context of insurance.129 A moratorium could be beneficial in the 
area of genetic discrimination because it is a temporary measure, and 
such impermanence allows for the moratorium to change as the 
understanding of genetic discrimination expands.130 Nonetheless, 
because it is not permanent, its use would still require the legislature to 
develop a plan for more enduring legal protections for victims of 
discrimination.131 Moratoriums could be implemented in areas 
identified as genetic discrimination trouble spots while the problem is 
still developing; which would avoid creating concrete legislation until 
the breadth and scope of the issue is understood. Returning to the 
example set forth earlier, consider a state that has identified insidious 
genetic discrimination in mortgage lending.132 The state may issue a 
moratorium prohibiting banks from using genetic information when 
considering the eligibility of borrowers for a ten-year period. During 
that time, lawmakers could develop a more complete understanding of 
what specific protections need to be afforded which would result in 
effective legislation tailored to protect against such discrimination. 
Passage of such legislation would then render the need for the 
moratorium obsolete. 
A different approach is used in Albania, where genetic 
nondiscrimination is understood as a fundamental human right, and is 
directly addressed in Albanian human rights legislation.133 Though 
“[b]roadly formulated” to afford expansive protection from genetic 
discrimination, this approach is subject to the interpretation of the 
 
128 See M. Otlowski et al., Genetic Discrimination: International Perspectives, 13 
ANN. REV. GENOMICS HUM. GENETICS 433, 443 (2012); see also Yann Joly et 
al., Comparative Approaches to Genetic Discrimination: Chasing Shadows?, 33 
TRENDS IN GENETICS 299, 299–300 (2017). 
129 Joly et al., supra note 128, at 299 (describing the moratorium Britain has for the 
use of genetic information in providing health insurance policies). 
130 Id. at 300. 
131 Moratorium, CORNELL L. SCH.: LEGAL INFO. INST., https://www.law.cornell.edu
/wex/moratorium [https://perma.cc/YQ5N-YQMN]. 
132 See supra text accompanying note 109. 
133 See Joly et al., supra note 128, at 300. 
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courts and “statutory exceptions.”134 Because genetic information is 
amalgamated with other broadly defined issues of human rights found 
in the legislation, its judicial interpretation is malleable. In one sense, 
judicial interpretation of the legislation could shore up ambiguities 
regarding when and how protection is afforded against genetic 
discrimination. In another sense, this malleability could also result in 
inadvertent lapses in justice if the legislation is not consistently 
applied. While broad legislation could be subject to the same shortfalls 
in GINA, the benefits of this approach are found in the nuances of 
judicial interpretation and application, which could fill any gaps left in 
situation-specific legislation on genetic discrimination.135 In any case, 
this is a model better suited for the final stages of genetic 
discrimination reform, which would occur after the substantive law 
governing genetic discrimination among the states is solidified or the 
uniform law is enacted at the federal level. 
Finally, states could also use GINA as a template to adopt 
categorical prohibitions against specific patterns of genetic 
discrimination as they arise. Unlike the other options, this approach is 
already in use in California.136 This could be a beneficial approach, as 
it allows the state to tailor the genetic antidiscrimination law to its 
specific needs.137 For example, bans on genetic discrimination in 
education may exist in one state at a given time, while another state 
prohibits such discrimination in money lending. Of these three 
potential models for legislation that presented above, no single one can 
be expected to fit each state’s needs perfectly. The states may vary in 
the method of effectuating legislative protections against genetic 
discrimination, but the methods should be appropriate for the pursuit 




135 See Eduardo Ferrer Mac-Gregor, What Do We Mean When We Talk About 
Judicial Dialogue?: Reflections of a Judge of the Inter-American Court of 
Human Rights, 30 HARV. HUM. RTS. J. 89, 90–91 (2017) (discussing how courts 
adapt to changing legal circumstances impacting human rights by looking to 
each other through a concept called “judicial dialogue”). 
136 See generally CalGINA, ch. 261, 2011 Cal. Stat. 2774 (codified in scattered 
sections of the California Codes) (illustrating an example of an already enacted 
state level categorical ban on genetic discrimination in several contexts). 
137 Joly et al., supra note 128, at 300 (this approach could be referred to as 
“Sectoral prohibition”). 
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V. CONCLUSION 
The infancy of genetic discrimination awareness in areas other 
than those afforded protection in GINA creates the perfect opportunity 
to create legislation before insidious discrimination can occur. Such 
legislation would propound the legislative intent of GINA, which was 
to preempt discrimination based on genetics before the practice could 
harm citizens.138 As science continues in its pursuit of understanding 
the human genome, problems implicated by the use of that information 
will persist. Over time, the understanding of the human genome will 
become more robust. As a result, legislation that protects against its 
misuse for discriminatory purposes should be equally comprehensive. 
The creation of legislation at the state level would allow states to learn 
from one another regarding the areas needing protections and how to 
effectuate those protections. This goal for effective genetic 
antidiscrimination law would be facilitated by making the changes in 
an incremental fashion to allow the issue of genetic discrimination to 
become clearer, thus preventing ineffective predictive federal 
legislation and protecting the rights of citizens in an ever-evolving 
modern society. 
 
138 See Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 2000ff 
(2018). 
